摘要
应用免疫组织化学方法对40例大肠腺癌P53蛋白表达进行检查,探讨P53蛋白表达水平与大肠腺癌各病理因素及预后的关系。发现50%(20/40)大肠腺癌组织中存在P53蛋白表达,其表达程度与大肠腺癌各项病理因素无关;P53蛋白表达阳性患者5年生存率为25%(5/20),明显低于P53蛋白表达阴性组的60%(12/20),P<0.05。结果提示:P53免疫组化检测可以作为判断大肠腺癌预后的指标。
? The expression of P53 protein in 40 cases of large bowel adenocarcinoma was studied immunohistochemically by use of a monoclonal antibody DO7 in this study. And immunoreactivity was found in 50% of them. The pattern of P53 expression was mainly detected in the nuclei of the tumor cells. No significant correlation between the expression of P53 and tumor size, pattern of growth, differention or lymph node metastasis was found. However patients with P53 positive tumors had a greater relative risk of death compared with those with P53 negative tumors. The 5 year survival rate was 25% of 20 patients with P53 positive tumors and 65% of the patients with P53 negative tumor. There was a significant different in the rate between the two groups of patients(P<0.05).The result suggest that the immunoreactivity of P53 may be act as a prognostic indicator in adenocarcinoma of large bowel.
关键词
肠肿瘤
腺癌/病理学
抑癌基因
免疫组化
预后
MeSH intestinal neoplasms
adenocarcinoma/PA
gene expression regulation
prognosis